3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Philadelphia Chromosome
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Blast Crisis
1
Interventions
ponatinib
4
Methotrexate
4
Cyclophosphamide
4
merphos
3
fludarabine phosphate
3
Whole-Body Irradiation
3
Tacrolimus
2
Rituximab
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Melphalan
2
Cytarabine
2
CT-P10
2
Busulfan
2
venetoclax
1
prednylidene
1
pegylated granulocyte colony-stimulating factor
1
letermovir
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
deltacortene
1
blinatumomab
1
auricularum
1
Vincristine
1
Thiotepa
1
Stem Cell Transplantation
1
Specimen Handling
1
Sirolimus
1
Prednisone
1
N,N-dicyclohexyl-isoborneol-10-sulfonamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid, Accelerated Phase
×
bosutinib
×
90 days
×
Clear all
No trials found.